Search results
- 4.3900Add to watchlist-0.0200 (-0.45%)As of Tue. Jul 16, 2024 3:47 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open4.4100High4.6000Low4.3666
- Mkt Cap3.67MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close4.410052 Wk. Low3.410052 Wk. High90.6500
Related stocks
4 days ago · Should You Buy or Sell ZyVersa Therapeutics Stock? Get The Latest ZVSA Stock Analysis, Price Target, Headlines, and Short Interest at MarketBeat.
- kcashmere@zyversa.com
- (754) 231-1688
- 7
3 days ago · Zacks' proprietary data indicates that ZyVersa Therapeutics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the ZVSA shares relative to the market in the...
5 days ago · Company profile for ZyVersa Therapeutics, Inc. (ZVSA) with a description, list of executives, contact details and other key facts.
- United States
- Biotechnology
- 2014
- Healthcare
4 days ago · View ZyVersa Therapeutics (NASDAQ:ZVSA) historical prices, past price performance, and an advanced ZVSA stock chart at MarketBeat.
- 345 N Reid Place, Suite 620, Sioux Falls, 57103, SD
- contact@marketbeat.com
- (844) 978-6257
4 days ago · What's going on at ZyVersa Therapeutics (NASDAQ:ZVSA)? Read today's ZVSA news from trusted media outlets at MarketBeat.
- 345 N Reid Place, Suite 620, Sioux Falls, 57103, SD
- contact@marketbeat.com
- (844) 978-6257
4 days ago · Detailed statistics for ZyVersa Therapeutics, Inc. (ZVSA) stock, including valuation metrics, financial numbers, share information and more.
4 days ago · Market Cap Chart. Since December 21, 2021, ZyVersa Therapeutics's market cap has decreased from $96.70M to $4.09M, a decrease of -95.77%. That is a compound annual growth rate of -70.95%.